Cat Allergy

Viral Mucosal Reprogramming

Effectiveness of an Air Purifier on Asthmatic and Cat-allergic Subjects in the ALYATEC Environmental Exposure Chamber

Diagnostic Accuracy of the MADx Multi Array Xplorer (MAX 45k) Automated Laboratory System and the MADx Allergy Explorer Version 2 (ALEX²) - IgE Multiplex Test for the Diagnosis of Pre-defined Groups of Specific High-priority Allergens

Study in Cat-Allergic Patients With Asthma to Evaluate the Efficacy of a Single Dose of REGN1908-1909 to Reduce Bronchoconstriction Upon Cat Allergen Challenge

Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy

A Randomized Prospective Clinical Trial of Fel d 1 Peptide Immunotherapy

Phase III Cat-PAD Follow-on Study

Evaluation of a New Self-assessed, Home-based Symptom Score in Cat Allergic Patients

Evaluation of a New Self-Assessed, Home-Based Symptom Score Test in Cat Allergic Patients

Identification of Potential Biomarkers of Peptide Immunotherapy. Part 2 - Gene Array Analysis

The Effects of Omalizumab (Anti-IgE) on the Late-phase Response to Nasal Allergen Challenge

Safety Evaluation of an Experimental Treatment, Intradermal Human Fcγ1-Fel d1 Fusion Protein (GFD), for Cat Allergy

Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis

An Optional Two Year Follow Up Study to Study CP005A

Cat-PAD Follow on Study

Cat-PAD Exposure Chamber Study

Exposure Chamber Trial With Cat Immunotherapy

Safety of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects With Controlled Asthma

Effectiveness of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects

Safety of Cat-PAD in Cat Allergic Subjects